Business Of Biotech
Een podcast door Matt Pillar - Maandagen
241 Afleveringen
-
Lessons From The Bone Therapeutics/Medsenic Merger With BioSenic's François Rieger, Ph.D.
Gepubliceerd: 20-3-2023 -
TCRs In Personalized Oncology With BlueSphere Bio's Keir Loiacono
Gepubliceerd: 13-3-2023 -
BoB@JPM: Self-Replicating RNA With Elixirgen's Akihiro Ko
Gepubliceerd: 6-3-2023 -
BoB@JPM: Gene Writing With Tessera's Michael Severino, M.D.
Gepubliceerd: 27-2-2023 -
BoB@JPM: Post-IPO With Bolt Biotherapeutics' Drs. Randall Schatzman and Edith Perez
Gepubliceerd: 20-2-2023 -
BoB@JPM: Academia To Industry With Oncolytics' Matt Coffey, Ph.D.
Gepubliceerd: 13-2-2023 -
BoB@JPM: Support Of A Blossoming Pipeline With Sangamo's Sandy Macrae, Ph.D.
Gepubliceerd: 6-2-2023 -
Building A Better COVID Vaccine With Ocugen's Shankar Musunuri, Ph.D.
Gepubliceerd: 30-1-2023 -
Modality-Agnostic Drug Discovery With Cullinan Oncology's Nadim Ahmed
Gepubliceerd: 23-1-2023 -
Women In Biotech With Bill & Melinda Gates MRI's Piper Trelstad, Ph.D.
Gepubliceerd: 16-1-2023 -
Computational Drug Discovery With Gain Therapeutics' Matthias Alder
Gepubliceerd: 9-1-2023 -
Dissecting Spesolimab's Approval With Boehringer Ingelheim's Carine Boustany
Gepubliceerd: 2-1-2023 -
AI & Computational Biology With Recursion's Chris Gibson, Ph.D.
Gepubliceerd: 26-12-2022 -
Allan Shaw On Financing Biopharma Innovation
Gepubliceerd: 19-12-2022 -
Gene Therapy For Chronic Inflammation With Xalud's Howard Rutman, M.D.
Gepubliceerd: 12-12-2022 -
The Antibody Engine With Abpro's Chan Brothers
Gepubliceerd: 5-12-2022 -
In-Vivo CAR T Update With Umoja Biopharma's David Fontana, Ph.D.
Gepubliceerd: 28-11-2022 -
RNA-Based Therapeutics With Nutcracker Therapeutics' Dr. Geoff Nosrati
Gepubliceerd: 21-11-2022 -
Tick-Derived Therapeutic Molecules With Akari Therapeutics' Rachelle Jacques
Gepubliceerd: 14-11-2022 -
Product vs. Platform With Surface's Vito Palombella, Ph.D. and Robert Ross, M.D.
Gepubliceerd: 7-11-2022
The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, and regulatory challenges you’ll face as you navigate your company from an idea to success in the clinic. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by Bioprocess Online and Life Science Connect and brought to you by Cytiva.
